130 related articles for article (PubMed ID: 8575100)
21. Effects of osmotic-release methylphenidate in attention-deficit/hyperactivity disorder as measured by event-related potentials.
Sawada M; Iida J; Ota T; Negoro H; Tanaka S; Sadamatsu M; Kishimoto T
Psychiatry Clin Neurosci; 2010 Oct; 64(5):491-8. PubMed ID: 20923428
[TBL] [Abstract][Full Text] [Related]
22. Topography of auditory and visual P300 in normal children.
Sangal RB; Sangal JM
Clin Electroencephalogr; 1996 Jan; 27(1):46-51. PubMed ID: 8719502
[TBL] [Abstract][Full Text] [Related]
23. [Stimulant therapy in children].
Steinhausen HC
Pharmacopsychiatria; 1982 Nov; 15(6):181-2. PubMed ID: 6130534
[No Abstract] [Full Text] [Related]
24. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
Stevenson RD; Wolraich ML
Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
[TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder.
Castellanos FX; Elia J; Kruesi MJ; Marsh WL; Gulotta CS; Potter WZ; Ritchie GF; Hamburger SD; Rapoport JL
Neuropsychopharmacology; 1996 Feb; 14(2):125-37. PubMed ID: 8822535
[TBL] [Abstract][Full Text] [Related]
26. [Cognitive evoked potentials in the hyperactivity attention deficit disorder].
Idiazábal Alecha M; Palencia Taboada AB; Sangorrín J; Espadaler-Gamissans JM
Rev Neurol; 2002 Feb 16-28; 34(4):301-5. PubMed ID: 12022041
[TBL] [Abstract][Full Text] [Related]
27. ABR and auditory P300 findings in children with ADHD.
Schochat E; Scheuer CI; Andrade ER
Arq Neuropsiquiatr; 2002 Sep; 60(3-B):742-7. PubMed ID: 12364942
[TBL] [Abstract][Full Text] [Related]
28. Pemoline (Cylert): market withdrawal.
Hogan V
CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
[No Abstract] [Full Text] [Related]
29. Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
Marcus SC; Durkin M
J Am Acad Child Adolesc Psychiatry; 2011 May; 50(5):480-9. PubMed ID: 21515197
[TBL] [Abstract][Full Text] [Related]
30. Sleep practitioners need to be aware of new changes in the labeling of pemoline (CYLERT).
Littner M
Sleep; 1999 Nov; 22(7):833. PubMed ID: 10566901
[No Abstract] [Full Text] [Related]
31. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.
Pelham WE; Swanson JM; Furman MB; Schwindt H
J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1504-13. PubMed ID: 8543519
[TBL] [Abstract][Full Text] [Related]
32. Stimulant medications in adults with attention deficit disorder.
Gauthier M
Can J Psychiatry; 1984 Aug; 29(5):435-40. PubMed ID: 6148139
[TBL] [Abstract][Full Text] [Related]
33. Pemoline in adult attention deficit hyperactivity disorder: predictors of nonresponse.
Heiligenstein E; Anders J
J Am Coll Health; 1997 Mar; 45(5):225-9. PubMed ID: 9069682
[TBL] [Abstract][Full Text] [Related]
34. Treatment of chronic cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline.
Weiss RD; Pope HG; Mirin SM
Drug Alcohol Depend; 1985 May; 15(1-2):69-72. PubMed ID: 4017880
[TBL] [Abstract][Full Text] [Related]
35. Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder.
Zametkin AJ; Linnoila M; Karoum F; Sallee R
Am J Psychiatry; 1986 Mar; 143(3):359-62. PubMed ID: 2420216
[TBL] [Abstract][Full Text] [Related]
36. [Cognitive evoked potentials and executive functions in children with attention deficit hyperactivity disorder].
Roca P; Mulas F; Presentación-Herrero MJ; Ortiz-Sánchez P; Idiazábal-Alecha MA; Miranda-Casas A
Rev Neurol; 2012 Feb; 54 Suppl 1():S95-103. PubMed ID: 22374778
[TBL] [Abstract][Full Text] [Related]
37. Pemoline in attention deficit disorder and alcoholism: a case study.
Turnquist K; Frances R; Rosenfeld W; Mobarak A
Am J Psychiatry; 1983 May; 140(5):622-4. PubMed ID: 6303137
[TBL] [Abstract][Full Text] [Related]
38. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
Conners CK
Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
[No Abstract] [Full Text] [Related]
39. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
[TBL] [Abstract][Full Text] [Related]
40. [Studies of evoked potentials in children with the syndrome of attention deficit and hyperactivity].
Smeyers P
Rev Neurol; 1999 Feb; 28 Suppl 2():S173-6. PubMed ID: 10778509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
